Design Therapeutics, Inc.
NASDAQ:DSGNBiotechnology
+$0.19 today
- Market cap
- $630.12M
- Beta
- 1.66
- P/E (TTM)
- -10.7
- EPS (TTM)
- -$1.13
Volume 0.29M
Average 0.74M
Dividends
Design Therapeutics, Inc. dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
—
Shareholder Yield
0.00%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 0.0%, so compare payout growth against earnings coverage.
Competitor dividends
How does Design Therapeutics, Inc. compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
PTC Therapeutics, Inc. NASDAQ:PTCT | $5.30B | 0.00% | $0.00 | 0.00% | 0.00% |
Ionis Pharmaceuticals, Inc. NASDAQ:IONS | $4.84B | 0.00% | $0.00 | 0.00% | 0.00% |
Dyne Therapeutics, Inc. NASDAQ:DYN | $3.22B | 0.00% | $0.00 | 0.00% | 0.00% |
Stoke Therapeutics, Inc. NASDAQ:STOK | $1.75B | 0.00% | $0.00 | 0.00% | 0.00% |
Sarepta Therapeutics, Inc. NASDAQ:SRPT | $1.72B | 0.00% | $0.00 | 0.00% | 0.00% |
Solid Biosciences Inc. NASDAQ:SLDB | $763.42M | 0.00% | $0.00 | 0.00% | 0.00% |
Wave Life Sciences Ltd. NASDAQ:WVE | $617.33M | 0.00% | $0.00 | 0.00% | 0.00% |
Larimar Therapeutics, Inc. NASDAQ:LRMR | $313.73M | 0.00% | $0.00 | 0.00% | 0.00% |
PepGen Inc. NASDAQ:PEPG | $301.98M | 0.00% | $0.00 | 0.00% | 0.00% |
Fulcrum Therapeutics, Inc. NASDAQ:FULC | $287.64M | 0.00% | $0.00 | 0.00% | 0.00% |
Questions
Dividend questions
Common questions about DSGN's dividend, answered from reported figures.
Does DSGN stock pay dividends?
Design Therapeutics, Inc. (DSGN) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is DSGN's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.